Gage Rensch, MD
Dermatology · Omaha, NENPI 1942706650
Payments from drug & device makers
Across 455 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sun Pharmaceutical Industries Inc.$900
- Johnson & Johnson$858
- Sanofi$842
- Lilly USA, LLC$801
- Amgen$722
- plus $6K from 28 others
What the payments were for
- Food & beverage$10,70797%
- Education$3253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,299 |
| Sun Pharmaceutical Industries Inc. | 42 | $900 |
| Johnson & Johnson | 39 | $858 |
| Sanofi | 29 | $842 |
| Lilly USA, LLC | 46 | $801 |
| Amgen | 21 | $722 |
| UCB, Inc. | 23 | $609 |
| Convatec Inc. | 21 | $585 |
| Incyte Corporation | 24 | $560 |
| Regeneron Healthcare Solutions, Inc. | 15 | $555 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $552 |
| E.r. Squibb & Sons, L.L.C. | 26 | $476 |
| Pfizer | 28 | $324 |
| LEO Pharma Inc. | 13 | $310 |
| Galderma Laboratories, L.p. | 10 | $298 |
| Novartis | 13 | $290 |
| Journey Medical Corporation | 3 | $168 |
| Almirall LLC | 5 | $140 |
| Merz North America, Inc. | 1 | $134 |
| Kerecis Limited | 3 | $125 |
| Arcutis Biotherapeutics, Inc. | 4 | $77 |
| Bristol Myers Squibb | 1 | $62 |
| Genentech USA, Inc. | 2 | $44 |
| Biofrontera Inc. | 2 | $40 |
| Organogenesis Inc. | 1 | $33 |
| Integra Lifesciences Corporation | 1 | $32 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $32 |
| Dermavant Sciences, Inc. | 2 | $30 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Therakos LLC | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Krystal Biotech Inc | 1 | $21 |
| Botanix SB Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,032 in reported general payments places this provider in the 80th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 23 | $1,938 |
| Ketoconazole | 60 | $935 |
| Doxycycline Monohydrate | 41 | $785 |
| Triamcinolone Acetonide | 43 | $376 |
| Dutasteride | 15 | $269 |
| Mupirocin | 37 | $254 |
| Minoxidil | 21 | $110 |
| Hydrocortisone | 17 | $95 |
| Cefadroxil | 12 | $73 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Omaha
- Joel SchlessingerOmaha$5.5M
- Mathew DaveyOmaha$389K
- Erin BarrettOmaha$144K
- Rachel PersonOmaha$98K
- Sarah LonowskiOmaha$89K
- James ShehanOmaha$51K
- Herschel StollerOmaha$10K
- Deirdre StolmeierOmaha$10K
- Melissa DarlingOmaha$10K
- Christopher HuerterOmaha$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.